Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

SELL
$74.26 - $84.51 $1.31 Million - $1.49 Million
-17,681 Reduced 87.1%
2,618 $216,000
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $498,590 - $638,312
-7,300 Reduced 26.45%
20,299 $1.51 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $23,145 - $30,148
281 Added 1.03%
27,599 $2.28 Million
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $559,568 - $829,778
6,469 Added 31.03%
27,318 $2.6 Million
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $2.74 Million - $3.45 Million
-26,914 Reduced 56.35%
20,849 $2.45 Million
Q4 2021

Feb 15, 2022

BUY
$106.37 - $130.68 $2.91 Million - $3.57 Million
27,311 Added 133.54%
47,763 $6.19 Million
Q3 2021

Nov 15, 2021

SELL
$102.91 - $122.75 $94,368 - $112,561
-917 Reduced 4.29%
20,452 $2.32 Million
Q2 2021

Aug 16, 2021

SELL
$83.84 - $104.76 $68,245 - $85,274
-814 Reduced 3.67%
21,369 $2.21 Million
Q1 2021

May 14, 2021

BUY
$78.68 - $90.67 $42,251 - $48,689
537 Added 2.48%
22,183 $1.86 Million
Q4 2020

Feb 12, 2021

SELL
$71.69 - $91.23 $189,118 - $240,664
-2,638 Reduced 10.86%
21,646 $1.98 Million
Q3 2020

Nov 13, 2020

SELL
$67.19 - $87.44 $68,063 - $88,576
-1,013 Reduced 4.0%
24,284 $1.94 Million
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $913,102 - $1.22 Million
15,869 Added 168.32%
25,297 $1.75 Million
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $610,314 - $943,245
-11,645 Reduced 55.26%
9,428 $1.78 Million
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $3,585 - $4,104
50 Added 0.24%
21,073 $4.92 Million
Q2 2019

Aug 14, 2019

BUY
$55.74 - $64.41 $136,228 - $157,418
2,444 Added 13.15%
21,023 $3.88 Million
Q1 2019

May 20, 2019

BUY
$47.89 - $64.05 $431 - $576
9 Added 0.05%
18,579 $3.56 Million
Q4 2018

Feb 13, 2019

BUY
$46.41 - $56.94 $861,833 - $1.06 Million
18,570 New
18,570 $2.84 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Allstate Corp Portfolio

Follow Allstate Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.